SeekIn 思勤


    seek and you will find


  • About us

    Despite the significant increase of our knowledge about carcinogenesis and recent successful development of innovative cancer drugs, including targeted therapies and immunotherapies, cancer mortality has only slightly decreased in the past decades. Cancer early detection is probably the most cost-effective means to reduce cancer mortality as prognosis is much better when cancer is detected and treated at the early stage.

    SeekIn is a startup focusing on blood-based cancer early diagnosis with a mission to reduce cancer mortality by 10% in the screened population by 2030. Our proprietary ctDNA mutation detection technology has demonstrated its promise to identify asymptomatic cancer patients from general population.

  • In October 2020,Dr.Mao was invited to give a talk on TEDxTheBoud's annual meeting again(TEDxTheBund talk in 2018). As TED's vision is the power of ideas to change the world, his wish is to use early detection to control cancer, the emperor of all maladies.


    I hope that with all our efforts today, when we identify a positive case, the person will say to me,“Dr. Mao, no worries. I just have cancer”.


    —— Mao Mao

    MAOMAO's TEDxTheBund talk in 2020

  • Our solution

    multiplex, stepwise, cost-effective blood-based cancer screening

    A NGS test to capture cancer genetic features in plasma.

    To calculate cancer risk score.

    Non-invasive blood based screening method,10ml blood.


    ©2018 SeekIn Cancer. All Rights Reserved. 粤ICP备18059743号-1 粤公网安备 44030802000447号